Table 2 V. parahaemolyticus and V. vulnificus strains used in this study
From: PCR-based method for targeting 16S-23S rRNA intergenic spacer regions among Vibrio species
V. parahaemolyticus strains | V. vulnificus strains | ||||||
|---|---|---|---|---|---|---|---|
Strain | Country* | Source | ST# | Strain | Country* | Source | ST# |
AN-16000 | Bangladesh | Clinical | 3 | 98-783 DP-A1 | USA-LA | Environ. | 26 |
AN-2189 | Bangladesh | Clinical | 3 | 99-742 DP-A9 | USA-MS | Environ. | 22 |
AO-24491 | Bangladesh | Clinical | 3 | 99-736 DP-C7 | USA-FL | Environ. | 34 |
AP-11243 | Bangladesh | Clinical | 51 | 99-624 DP-C10 | USA-TX | Environ. | 17 |
428/00 | Spain | Clinical | 17 | 99-779 DP-D2 | USA-LA | Environ. | 51 |
UCM-V586 | Spain | Environ. | 45 | 99-796 DP-E7 | USA-FL | Environ. | 22 |
9808/1 | Spain | Clinical | 3 | 98-640 DP-E9 | USA-LA | Environ. | 24 |
906-97 | Peru | Clinical | 3 | ATL 6-1306 | USA-FL | Clinical | 16 |
357-99 | Peru | Clinical | 19 | ATL 71503 | USA-FL | Clinical | 16 |
VpHY191 | Thailand | Clinical | 3 | ATL 9579 | USA-TX | Clinical | 19 |
VpHY145 | Thailand | Clinical | 3 | ATL 61438 | USA-TX | Clinical | N/A |
KXV-641 | Japan | Clinical | 3 | ATL 9823 | USA-LA | Clinical | 37 |
98-605-A10 | USA-CT | Environ. | 31 | ATL 71491 | USA-TX | Clinical | 32 |
9546257 | USA-CA | Clinical | 32 | ATL 71504 | USA-LA | Clinical | 32 |
049-2A3 | USA-OR | Environ. | 57 | BUF 7211 | USA-FL | Clinical | N/A |
98-506-B103 | USA-VA | Environ. | 30 | DAL 8-9131 | USA-TX | Clinical | N/A |
98-548-D11 | USA-MA | Environ. | 34 | DAL 6-5000 | USA-LA | Clinical | 18 |
98-513-F52 | USA-LA | Environ. | 34 | FLA 8869 | USATX | Clinical | 40 |
DI-B9 160399 | USA-AL | Environ. | 25 | FLA 9509 | USA-LA | Clinical | 40 |
DI-B11 160399 | USA-AL | Environ. | 54 | LOS 6966 | USA-TX | Clinical | 2 |
DI-B-1 200600 | USA-AL | Environ. | 23 | LOS 7343 | USA-LA | Clinical | 32 |
HC-01-22 | USA-WA | Environ. | 43 | NSV 5736 | USA-AL | Clinical | 33 |
HC-01-06 | USA-WA | Environ. | 41 | NSV 5830 | USA-FL | Clinical | 52 |
K0976 | USA-AK | Environ. | 4 | NSV 5829 | USA-FL | Clinical | 16 |
K1202 | USA-AK | Environ. | 43 | ORL 1506 | USA-FL | Clinical | 16 |
K1296 | USA-AK | Environ. | 9 | ORL 8324 | USA-FL | Clinical | 37 |
K1317 | USA-AK | Environ. | 5 | ORL 8073 | USA-FL | Clinical | N/A |
029-1 (b) | USA-OR | Environ. | 36 | 10152 | USA-WA | Clinical | N/A |
10290 | USA-WA | Clinical | 37 | 10156 | USA-WA | Clinical | N/A |
10292 | USA-WA | Clinical | 50 | 10157 | USA-WA | Environ. | N/A |
10227 | USA-WA | Environ. | N/A | 10158 | USA-WA | Environ. | N/A |
10259 | USA-WA | Clinical | N/A | 10159 | USA-WA | Clinical | N/A |
10272 | USA-WA | Environ. | N/A | 10163 | USA-WA | Environ. | N/A |
10276 | USA-WA | Environ. | N/A | 10164 | USA-WA | Clinical | N/A |
10301 | USA-WA | Environ. | N/A | 10165 | USA-WA | Clinical | N/A |
10374 | USA-WA | Clinical | N/A | 10167 | USA-WA | Clinical | N/A |